Royal Harbor Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,157
Closed -$1.96M 78
2023
Q1
$1.96M Buy
4,157
+27
+0.7% +$13K 1.05% 29
2022
Q4
$2.19M Sell
4,130
-205
-5% -$109K 1.35% 26
2022
Q3
$2.19M Sell
4,335
-224
-5% -$118K 1.5% 24
2022
Q2
$2.34M Buy
4,559
+1,624
+55% +$816K 1.6% 22
2022
Q1
$1.5M Sell
2,935
-293
-9% -$141K 0.96% 30
2021
Q4
$1.62M Buy
3,228
+91
+3% +$41.2K 1.03% 26
2021
Q3
$1.23M Sell
3,137
-186
-6% -$77K 0.87% 41
2021
Q2
$1.33M Buy
3,323
+61
+2% +$24.3K 0.89% 38
2021
Q1
$1.21M Buy
3,262
+175
+6% +$60.6K 0.93% 33
2020
Q4
$1.08M Sell
3,087
-1
-0% -$335 0.91% 43
2020
Q3
$963K Sell
3,088
-2,348
-43% -$721K 0.9% 22
2020
Q2
$1.6M Buy
+5,436
New +$1.56M 1.58% 14

Other funds holding UNH

Royal Harbor Partners's UNH Position: Q2 2023 in Review

Royal Harbor Partners sold out of UnitedHealth (UNH) in Q2 2023, closing a stake of 4,157 shares — an estimated $1.96M sold.

Royal Harbor Partners first reported a position in UNH in Q2 2020 and held it in 12 quarters. The position peaked at $2.34M in Q2 2022. 3,128 funds tracked by Wall St. Rank hold UNH as of Q2 2023.

  • Royal Harbor Partners reported no remaining UnitedHealth position as of Q2 2023 after selling out during the quarter.
  • Royal Harbor Partners sold 4,157 UnitedHealth shares in Q2 2023, an estimated $1.96M.
  • Royal Harbor Partners first reported a position in UnitedHealth in Q2 2020 and held it in 12 quarters.
  • Royal Harbor Partners's UnitedHealth position peaked at $2.34M in Q2 2022.
  • 3,128 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2023.

Based on Royal Harbor Partners's 13F filing for Q2 2023, filed 24 Jul 2023.